Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Initial Results from a Phase 1/2 Study Evaluating Divesiran, a Novel Galnac Conjugated siRNA, in Patients with Polycythemia Vera (SANRECO)

Marina Kremyanskaya, Ronald Hoffman, Lee Ping Chew, Azizan Sharif, Boyan Semov, Ahlam Naila Kori, Hanlon Sia, Carolyn S. Grove, Ashley P Ng, Akash Kalro, Indu Raman, Ganesh Kasinathan, Olubunmi Oduwole, Monica Gomez-Palou, Henry Fok, Steve Romano, Curtis Rambaran, Alberto Martinez

Blood (2024) 144 (Supplement 1): 656.

https://doi.org/10.1182/blood-2024-205854

Published: 2024

Journal Articles

Health-Related Quality of Life in Adolescents and Young Adults Treated with Blinatumomab Consolidation for CD19+ Ph-Negative Acute Lymphoblastic Leukemia in the Australasian Lymphoma and Leukaemia Group (ALLG) ALL09 “Sublime” Study

Blood (2024) 144 (Supplement 1): 1445.

https://doi.org/10.1182/blood-2024-209043

Published: 2024

Journal Articles

Catch ’em all! CDK9’s RUNX1 mega evolution

Ashley P. Ng

Blood (2024) 144 (17): 1758–1759.

https://doi.org/10.1182/blood.2024026377

Published: 2024

Journal Articles

Hit the road JAK, don’t P-STAT, stem more!

Ashley P. Ng

Blood (2024) 144 (7): 683–684.

https://doi.org/10.1182/blood.2024025441

Published: 2024

Journal Articles

A Rare Cell State Underpins Diverse Mechanisms of Adaptive Resistance to CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

James A Kuzich, Laure Talarmain, Dane Vassiliadis, Andrew A Guirguis, Jack D Chan, Paul A Beavis, Phillip K Darcy, Ashley P Ng, Mark A Dawson

Blood (2023) 142 (Supplement 1): 887.

https://doi.org/10.1182/blood-2023-191111

Published: 2023

Journal Articles

Improved MRD Negativity Rates in Adverse Genomic Risk B-ALL Patients with Chemotherapy / Blinatumomab Induction: Experience from the Australasian Leukaemia Lymphoma Group (ALLG) ALL06/09 Studies

Blood (2023) 142 (Supplement 1): 1609.

https://doi.org/10.1182/blood-2023-178473

Published: 2023

Journal Articles

All wired up: heptads in hematopoiesis

Ashley P. Ng

Blood (2023) 142 (17): 1407–1409.

https://doi.org/10.1182/blood.2023022014

Published: 2023

Journal Articles

Iron homeostasis governs erythroid phenotype in polycythemia vera

Blood (2023) 141 (26): 3199–3214.

https://doi.org/10.1182/blood.2022016779

Published: 2023

Includes: Supplemental data

Journal Articles

Blinatumomab in Combination with an Intensive Pediatric Protocol Results in High Rates of Day 79 MRD Negativity in Adolescent and Young Adult Acute Lymphoblastic Leukemia - Preliminary Results of the Australasian Leukaemia and Lymphoma Group (ALLG) ALL09 "Sublime” Study

Blood (2022) 140 (Supplement 1): 8971–8972.

https://doi.org/10.1182/blood-2022-168568

Published: 2022

Journal Articles

Diagnostic Utility of Multimodal Genomic Profiling for Molecular Classification and MRD Assessment in Adult B-Cell Acute Lymphoblastic Leukemia

Georgina L Ryland, Ashish Bajel, Michael Dickinson, Paul G Ekert, Oliver Hofmann, Maarten IJzerman, Ashley P Ng, Alicia Oshlack, Breon Schmidt, Ing S Tiong, Martin Vu, David Alan Westerman, Sean Grimmond, Piers Blombery

Blood (2021) 138 (Supplement 1): 274.

https://doi.org/10.1182/blood-2021-146396

Published: 2021

Journal Articles

Unraveling a T-ALL Tapestri

Ashley P. Ng

Blood (2021) 137 (6): 726–727.

https://doi.org/10.1182/blood.2020008467

Published: 2021

Journal Articles

Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis

Hai Vu Nguyen, Cassandra J. Vandenberg, Ashley P. Ng, Mikara R. Robati, Natasha S. Anstee, Joel Rimes, Edwin D. Hawkins, Suzanne Cory

Blood (2020) 135 (13): 1019–1031.

https://doi.org/10.1182/blood.2019003014

Published: 2020

Includes: Supplemental data

Journal Articles

I myelofibrosis! Veni VitD! Et tu, macrophage?

Ashley P. Ng

Blood (2019) 133 (15): 1613–1615.

https://doi.org/10.1182/blood-2019-02-900779

Published: 2019

Journal Articles

Identification of Potent BH3-Mimetic Combinations Targeting Pro-Survival Pathways in Human B-Cell Acute Lymphoblastic Leukemia

Donia M Moujalled, PhD, Diane T Hanna, Giovanna Pomilio, Veronique Litalien, Shaun Fleming, Marie Chanrion, Ana-Leticia Maragno, Laurence Kraus-Berthier, Seong Lin Khaw, Guillaume Lessene, David Huang, Andrew W. Roberts, MBBS, PhD, Olivier Geneste, Paul G Ekert, Ashley P Ng, Andrew H Wei, MBBS,PhD

Blood (2018) 132 (Supplement 1): 567.

https://doi.org/10.1182/blood-2018-99-114051

Published: 2018

Journal Articles

Screening With Spirometry Is A Useful Predictor Of Later Development Of Non-Infectious Pulmonary Syndromes In Patients Undergoing Allogeneic Stem Cell Transplantation

Thompson A Philip, MBBS, FRACP, FRCPA, Andrew B M Lim, MBBS, FRACP, FRCPA, Mark Tacey, Ramzi Hijazi, MBBS, Ashley P. Ng, MBBS, BMedSc, PhD, FRACP, FRCPA, Jeffrey Szer, BMedSc, MBBS, FRACP, David Ritchie, MBBS, PhD, FRACP, FRCPA, Ashish R. Bajel, MBBS, FRACP, FRCPA

Blood (2013) 122 (21): 4603.

https://doi.org/10.1182/blood.V122.21.4603.4603

Published: 2013

Journal Articles

GFI1B Mutation Causes a Platelet Function Defect With Reduced Alpha-Granule Content and Abnormal Aggregation Response

Christopher M Ward, MB, CHB, PhD, Marie-Christine Morel-Kopp, PhD, Qiang Chen, BMed MSc, Hai Po Liang, PhD, Ashley P. Ng, MBBS, BMedSc, PhD, FRACP, FRCPA, Andrew W. Roberts, MBBS, PhD, Melanie Bahlo, PhD, William s Stevenson, MBBS, PhD

Blood (2013) 122 (21): 566.

https://doi.org/10.1182/blood.V122.21.566.566

Published: 2013

Journal Articles

Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice

Ashley P. Ng, Stephen J. Loughran, Donald Metcalf, Craig D. Hyland, Carolyn A. de Graaf, Yifang Hu, Gordon K. Smyth, Douglas J. Hilton, Benjamin T. Kile, Warren S. Alexander

Blood (2011) 118 (9): 2454–2461.

https://doi.org/10.1182/blood-2011-03-344739

Published: 2011

Includes: Supplemental data

Journal Articles

Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome

Ashley P. Ng, Craig D. Hyland, Donald Metcalf, Catherine L. Carmichael, Stephen J. Loughran, Ladina Di Rago, Benjamin T. Kile, Warren S. Alexander

Blood (2010) 115 (19): 3966–3969.

https://doi.org/10.1182/blood-2009-09-242107

Published: 2010

Includes: Supplemental data

Journal Articles

Thrombotic Thrombocytopenic Purpura: Is Plasma Exchange Enough? A Fifteen Year Australian Experience at the Royal Melbourne Hospital.

Ashley P. Ng, MB, BS, Natasha Frawley, M.B.B.S., Chris Hogan, M.B.B.S., Andrew Grigg, M.B.B.S., Solomon Cohney, M.B.B.S., Kathy Nicholls, M.B.B.S., Gavin Becker, M.B.B.S.

Blood (2006) 108 (11): 3991.

https://doi.org/10.1182/blood.V108.11.3991.3991

Published: 2006

Journal Articles

CD 138 Immunostaining of Bone Marrow Trephine Specimens Is the Most Sensitive Method for Quantifying Marrow Involvement in Patients with Plasma Cell Dyscrasias.

Ashley P. Ng, MBBS B Med Sci, Andrew Wei, M.B.BS, P.H.D., Dinesh Bhurani, M.B.BS, Peter Chappell, Frank Feleppa, Surender Juneja, M.B.BS MD(Path).

Blood (2005) 106 (11): 5071.

https://doi.org/10.1182/blood.V106.11.5071.5071

Published: 2005

NARROW

Initial Results from a Phase 1/2 Study Evaluating Divesiran, a Novel Galnac Conjugated siRNA, in Patients with Polycythemia Vera (SANRECO)

Health-Related Quality of Life in Adolescents and Young Adults Treated with Blinatumomab Consolidation for CD19+ Ph-Negative Acute Lymphoblastic Leukemia in the Australasian Lymphoma and Leukaemia Group (ALLG) ALL09 “Sublime” Study

Catch ’em all! CDK9’s RUNX1 mega evolution

Hit the road JAK, don’t P-STAT, stem more!

A Rare Cell State Underpins Diverse Mechanisms of Adaptive Resistance to CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

Improved MRD Negativity Rates in Adverse Genomic Risk B-ALL Patients with Chemotherapy / Blinatumomab Induction: Experience from the Australasian Leukaemia Lymphoma Group (ALLG) ALL06/09 Studies

All wired up: heptads in hematopoiesis

Iron homeostasis governs erythroid phenotype in polycythemia vera

Blinatumomab in Combination with an Intensive Pediatric Protocol Results in High Rates of Day 79 MRD Negativity in Adolescent and Young Adult Acute Lymphoblastic Leukemia - Preliminary Results of the Australasian Leukaemia and Lymphoma Group (ALLG) ALL09 "Sublime” Study

Diagnostic Utility of Multimodal Genomic Profiling for Molecular Classification and MRD Assessment in Adult B-Cell Acute Lymphoblastic Leukemia

Unraveling a T-ALL Tapestri

Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis

I myelofibrosis! Veni VitD! Et tu, macrophage?

Identification of Potent BH3-Mimetic Combinations Targeting Pro-Survival Pathways in Human B-Cell Acute Lymphoblastic Leukemia

Screening With Spirometry Is A Useful Predictor Of Later Development Of Non-Infectious Pulmonary Syndromes In Patients Undergoing Allogeneic Stem Cell Transplantation

GFI1B Mutation Causes a Platelet Function Defect With Reduced Alpha-Granule Content and Abnormal Aggregation Response

Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice

Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome

Thrombotic Thrombocytopenic Purpura: Is Plasma Exchange Enough? A Fifteen Year Australian Experience at the Royal Melbourne Hospital.

CD 138 Immunostaining of Bone Marrow Trephine Specimens Is the Most Sensitive Method for Quantifying Marrow Involvement in Patients with Plasma Cell Dyscrasias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only